NCT02645149 2026-02-27
Match Mel
Melanoma Institute Australia
Phase 2 Completed
Clinical Trials
9 trialsNCT04454489 2025-11-19
Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
Wake Forest University Health Sciences
Phase 2 Completed
NCT03623646 2025-08-08
CITHARE
Institut Claudius Regaud
Phase 2 Completed
NCT07015489 2025-06-11
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT02609386 2024-01-30
INSPIRE
Brooklyn ImmunoTherapeutics, LLC
Phase 2 Completed
NCT00101166 2018-02-28
Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT01347034 2016-05-23
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00673738 2015-10-08
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00558220 2007-11-14
R-MCEB
Czech Lymphoma Study Group
Phase 2 Completed